ロード中...
Neutralizing Antibodies and CD8(+) T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine Vectors
The high prevalence of preexisting immunity to adenovirus serotype 5 (Ad5) in human populations will likely limit the immunogenicity and clinical utility of recombinant Ad5 vector-based vaccines for human immunodeficiency virus type 1 and other pathogens. Ad5-specific neutralizing antibodies (NAbs)...
保存先:
| 主要な著者: | , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology
2004
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC353774/ https://ncbi.nlm.nih.gov/pubmed/14990686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.78.6.2666-2673.2004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|